OpenURL Connection Search

Select item for more details and to access through your institution.

Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma.
Published in:
Bone Marrow Transplantation, 2001, v. 28, n. 10, p. 923, doi. 10.1038/sj.bmt.1703265
By:
- Magagnoli, M;
- Sarina, B;
- Balzarotti, M;
- Castagna, L;
- Timofeeva, I;
- Nozza, A;
- Bertuzzi, A;
- Siracusano, L;
- Sinnone, M;
- Santoro, A
Publication type:
Article
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)
Published in:
2012
By:
- Rigacci L;
- Puccini B;
- Cortelazzo S;
- Gaidano G;
- Piccin A;
- D'Arco A;
- Freilone R;
- Storti S;
- Orciuolo E;
- Zinzani PL;
- Zaja F;
- Bongarzoni V;
- Balzarotti M;
- Rota-Scalabrini D;
- Patti C;
- Gobbi M;
- Carpaneto A;
- Liberati AM;
- Bosi A;
- Iannitto E
Publication type:
Journal Article
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 499, doi. 10.1038/bmt.2014.304
By:
- Castagna, L;
- Crocchiolo, R;
- Giordano, L;
- Bramanti, S;
- Carlo-Stella, C;
- Sarina, B;
- Chiti, A;
- Mauro, E;
- Gandolfi, S;
- Todisco, E;
- Balzarotti, M;
- Anastasia, A;
- Magagnoli, M;
- Brusamolino, E;
- Santoro, A
Publication type:
Article
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 12, p. 1552, doi. 10.1038/bmt.2014.267
By:
- Castagna, L;
- Bramanti, S;
- Furst, S;
- Giordano, L;
- Crocchiolo, R;
- Sarina, B;
- Mauro, E;
- Morabito, L;
- Bouabdallah, R;
- Coso, D;
- Balzarotti, M;
- Broussais, F;
- El-Cheikh, J;
- Stella, C C;
- Brusamolino, E;
- Blaise, D;
- Santoro, A
Publication type:
Article
Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 12, p. 1475, doi. 10.1038/bmt.2014.197
By:
- Castagna, L;
- Bramanti, S;
- Furst, S;
- Giordano, L;
- Crocchiolo, R;
- Sarina, B;
- Mauro, E;
- Morabito, L;
- Bouabdallah, R;
- Coso, D;
- Balzarotti, M;
- Broussais, F;
- El-Cheikh, J;
- Stella, C C;
- Brusamolino, E;
- Blaise, D;
- Santoro, A
Publication type:
Article
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 249, doi. 10.1038/bmt.2012.116
By:
- Crocchiolo, R;
- Castagna, L;
- Fürst, S;
- El-Cheikh, J;
- Faucher, C;
- Oudin, C;
- Granata, A;
- Bouabdallah, R;
- Coso, D;
- Chabannon, C;
- Balzarotti, M;
- Santoro, A;
- Blaise, D
Publication type:
Article
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 11, p. 1019, doi. 10.1038/sj.bmt.1705862
By:
- Magagnoli, M.;
- Spina, M.;
- Balzarotti, M.;
- Timofeeva, I.;
- Isa, L.;
- Michieli, M.;
- Capizzuto, R.;
- Morenghi, E.;
- Castagna, L.;
- Tirelli, U.;
- Santoro, A.
Publication type:
Article
Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 10, p. 1067, doi. 10.1038/sj.bmt.1704492
By:
- Magagnoli, M.;
- Castagna, L.;
- Bramanti, S.;
- Balzarotti, M.;
- Santoro, A.
Publication type:
Article
Reduced intensity conditioning regimens.
Published in:
Bone Marrow Transplantation, 2002, v. 30, n. 4, p. 207, doi. 10.1038/sj.bmt.1703626
By:
- Castagna, L.;
- Bertuzzi, A.;
- Nozza, A.;
- Siracusano, L.;
- Balzarotti, M.;
- Magagnoli, M.;
- Sarina, B.;
- Timofeeva, I.;
- Sinnone, M.;
- Grimoldi, M.G.;
- Fare, M.;
- Santoro, A.
Publication type:
Article
Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL).
Published in:
Hematological Oncology, 2023, v. 41, p. 408, doi. 10.1002/hon.3164_300
By:
- Iannitto, E.;
- Balzarotti, M.;
- Martelli, M.;
- Zinzani, P.;
- Tucci, A.;
- Di Rocco, A.;
- Cavallo, F.;
- Usai, S. V.;
- Guidetti, A.;
- Ravano, E.;
- Merli, F.;
- Botto, B.;
- Pelosini, M.;
- Tecchio, C.;
- Spina, M.;
- Derenzini, E.;
- Finotto, S.;
- Mola, B.;
- Pinto, A.;
- Zanni, E.
Publication type:
Article
A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY.
Published in:
Hematological Oncology, 2023, v. 41, p. 48, doi. 10.1002/hon.3163_19
By:
- Davies, A. J.;
- Zucca, E.;
- Ceriani, L.;
- Kryachok, I.;
- Ciccone, G.;
- Botto, B.;
- Balzarotti, M.;
- Tucci, A.;
- Rusconi, C.;
- Usai, S. V.;
- Pennese, E.;
- Arcaini, L.;
- Dabrowska‐Iwanicka, A.;
- Ferreri, A. J. M.;
- Merli, F.;
- Zhao, W.;
- Hodgson, D.;
- Rigacci, L.;
- Cellini, C.;
- Stelitano, C.
Publication type:
Article
DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN (LO) PATIENTS: A SUBSTUDY OF THE “ELDERLY PROJECT” BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.95_2880
By:
- Tucci, A.;
- Merli, F.;
- Fabbri, A.;
- Mancuso, S.;
- Sartori, R.;
- Storti, S.;
- Luminari, S.;
- Mammi, C.;
- Marcheselli, L.;
- Arcari, A.;
- Cavallo, F.;
- Zilioli, V. R.;
- Bottelli, C.;
- Re, A.;
- Gini, G.;
- Cox, M. C.;
- Puccini, B.;
- Pagani, C.;
- Balzarotti, M.;
- Spina, M.
Publication type:
Article
IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.49_2879
By:
- Martelli, M.;
- Zucca, E.;
- Botto, B.;
- Kryachok, I.;
- Ceriani, L.;
- Balzarotti, M.;
- Tucci, A.;
- Cabras, M. G.;
- Zilioli, V. R.;
- Rusconi, C.;
- Angrilli, F.;
- Arcaini, L.;
- Iwanicka, A. Dabrowska;
- Ferreri, Andrés J.M.;
- Merli, F.;
- Zhao, W.;
- Hodgson, D.;
- Ionescu, C.;
- Fosså, A.;
- Cwynarski, K.
Publication type:
Article
INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS IN PRIMARY TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: 5‐YEAR RESULTS OF THE IELSG30 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.48_2879
By:
- Conconi, A.;
- Chiappella, A.;
- Orsucci, L.;
- Gaidano, G.;
- Ferreri, Andrés J.M.;
- Balzarotti, M.;
- Tucci, A.;
- Botto, B.;
- Moccia, A.;
- Vanazzi, A.;
- Merli, F.;
- Tani, M.;
- Esposito, F.;
- Bonomini, L.;
- Vitolo, U.;
- Zucca, E.
Publication type:
Article
COPANLISIB IN COMBINATION WITH RITUXIMAB‐BENDAMUSTINE IN PATIENTS WITH RELAPSED‐REFRACTORY DLBCL: A MULTICENTRIC PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.167_2880
By:
- Novo, M.;
- Castellino, A.;
- Chiappella, A.;
- Ciccone, G.;
- Balzarotti, M.;
- Di Rocco, A.;
- Spina, M.;
- Vitolo, U.
Publication type:
Article
PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2019, v. 37, p. 253, doi. 10.1002/hon.62_2630
By:
- Balzarotti, M.;
- Ricardi, U.;
- Spina, M.;
- Monagheddu, C.;
- Tucci, A.;
- Cavallo, F.;
- Zanni, M.;
- Arcari, A.;
- Rusconi, C.;
- Sartori, R.;
- Merli, F.;
- Re, F.;
- Vitolo, U.;
- Dessi, D.;
- Melis, L.;
- Gaidano, G.;
- Chiti, A.;
- Deidda, M.;
- Santoro, A.;
- Ciccone, G.
Publication type:
Article
THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 248, doi. 10.1002/hon.58_2630
By:
- Spina, M.;
- Merli, F.;
- Puccini, B.;
- Cavallo, F.;
- Cabras, M.G.;
- Fabbri, A.;
- Angrilli, F.;
- Zilioli, V.R.;
- Marino, D.;
- Balzarotti, M.;
- Ladetto, M.;
- Cox, M.C.;
- Petrucci, L.;
- Arcari, A.;
- Gini, G.;
- Chiappella, A.;
- Hohaus, S.;
- Musuraca, G.;
- Merli, M.;
- Sartori, R.
Publication type:
Article
IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 244, doi. 10.1002/hon.54_2630
By:
- Rusconi, C.;
- Tucker, D.;
- Bernard, S.;
- Muzi, C.;
- Crucitti, L.;
- Stefani, P.;
- Cox, M.;
- Gini, G.;
- Re, A.;
- Sciarra, R.;
- Liberati, A.;
- Morello, L.;
- Arcari, A.;
- Mannina, D.;
- Vitagliano, O.;
- Sartori, R.;
- Chiappella, A.;
- Balzarotti, M.;
- Vitolo, U.;
- Thieblemont, C.
Publication type:
Article
DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI.
Published in:
Hematological Oncology, 2019, v. 37, p. 291, doi. 10.1002/hon.100_2630
By:
- Mazza, R.;
- Spina, M.;
- Califano, C.;
- Gaudio, F.;
- Carella, M.;
- Consoli, U.;
- Palombi, F.;
- Musso, M.;
- Pulsoni, A.;
- Kovalchuk, S.;
- Bonfichi, M.;
- Ricci, F.;
- Fabbri, A.;
- Liberati, A.;
- Rodari, M.;
- Giordano, L.;
- Balzarotti, M.;
- Gallamini, A.;
- Ricardi, U.;
- Chauvie, S.
Publication type:
Article
PET‐DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2019, v. 37, p. 253, doi. 10.1002/hon.62_2630
By:
- Balzarotti, M.;
- Ricardi, U.;
- Spina, M.;
- Monagheddu, C.;
- Tucci, A.;
- Cavallo, F.;
- Zanni, M.;
- Arcari, A.;
- Rusconi, C.;
- Sartori, R.;
- Merli, F.;
- Re, F.;
- Vitolo, U.;
- Dessi, D.;
- Melis, L.;
- Gaidano, G.;
- Chiti, A.;
- Deidda, M.;
- Santoro, A.;
- Ciccone, G.
Publication type:
Article
IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 244, doi. 10.1002/hon.54_2630
By:
- Rusconi, C.;
- Tucker, D.;
- Bernard, S.;
- Muzi, C.;
- Crucitti, L.;
- Stefani, P.;
- Cox, M.;
- Gini, G.;
- Re, A.;
- Sciarra, R.;
- Liberati, A.;
- Morello, L.;
- Arcari, A.;
- Mannina, D.;
- Vitagliano, O.;
- Sartori, R.;
- Chiappella, A.;
- Balzarotti, M.;
- Vitolo, U.;
- Thieblemont, C.
Publication type:
Article
THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 248, doi. 10.1002/hon.58_2630
By:
- Spina, M.;
- Merli, F.;
- Puccini, B.;
- Cavallo, F.;
- Cabras, M.G.;
- Fabbri, A.;
- Angrilli, F.;
- Zilioli, V.R.;
- Marino, D.;
- Balzarotti, M.;
- Ladetto, M.;
- Cox, M.C.;
- Petrucci, L.;
- Arcari, A.;
- Gini, G.;
- Chiappella, A.;
- Hohaus, S.;
- Musuraca, G.;
- Merli, M.;
- Sartori, R.
Publication type:
Article
DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI.
Published in:
Hematological Oncology, 2019, v. 37, p. 291, doi. 10.1002/hon.100_2630
By:
- Mazza, R.;
- Spina, M.;
- Califano, C.;
- Gaudio, F.;
- Carella, M.;
- Consoli, U.;
- Palombi, F.;
- Musso, M.;
- Pulsoni, A.;
- Kovalchuk, S.;
- Bonfichi, M.;
- Ricci, F.;
- Fabbri, A.;
- Liberati, A.;
- Rodari, M.;
- Giordano, L.;
- Balzarotti, M.;
- Gallamini, A.;
- Ricardi, U.;
- Chauvie, S.
Publication type:
Article
BIODLCL04: THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE, MYC, BCL2, AND TP53 IN UNTREATED POOR-RISK DIFFUSE LARGE B-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 157, doi. 10.1002/hon.2438_12
By:
- Chiappella, A.;
- Agostinelli, C.;
- Martelli, M.;
- Evangelista, A.;
- Fabbri, M.;
- Melle, F.;
- Motta, G.;
- Righi, S.;
- Novero, D.;
- Balzarotti, M.;
- Cabras, M.G.;
- Carella, A.M.;
- Gotti, M.;
- Pavone, V.;
- Tucci, A.;
- Ladetto, M.;
- Gaidano, G.;
- Vitolo, U.;
- Pileri, S.A.
Publication type:
Article
LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R-CVP WITH R-CHOP AND R-FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 34, doi. 10.1002/hon.2437_14
By:
- Luminari, S.;
- Tarantino, V.;
- Anastasia, A.;
- Boccomini, C.;
- Chiarenza, A.;
- Rigacci, L.;
- Angelucci, E.;
- Ferrari, A.;
- Pulsoni, A.;
- Rattotti, S.;
- Angrilli, F.;
- Gaidano, G.;
- Stelitano, C.;
- Bertoldero, G.;
- Cascavilla, N.;
- Salvi, F.;
- Ferreri, A.J.;
- Vallisa, D.;
- Balzarotti, M.;
- Cox, M.C.
Publication type:
Article
Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour.
Published in:
British Journal of Cancer, 2003, v. 89, n. 7, p. 1159, doi. 10.1038/sj.bjc.6601304
By:
- Bertuzzi, A.;
- Castagna, L.;
- Quagliuolo, V.;
- Ginanni, V.;
- Compasso, S.;
- Magagnoli, M.;
- Balzarotti, M.;
- Nozza, A.;
- Siracusano, L.;
- Timofeeva, I.;
- Sarina, B.;
- Parra, H. Soto;
- Santoro, A.
Publication type:
Article

Found: 26